2440

NEW ZEALAND GAZETTE, No. 97

Prochlorperazine; in packs containing not more than
10 tablets for the treatment of nausea associated with
migraine

Salicylic acid; in medicines containing more than 40%

Silver sulfadiazine; except for external use in packs
containing 50 grams or less

Sodium picosulfate; in preparations for bowel cleansing
prior to diagnostic, medical or surgical procedures

Schedule 3

Pharmacy-only Medicines

Acetylcysteine; for oral use in medicines containing more
than 1 gram per recommended daily dose

Aciclovir; for external use for the treatment of herpes
labialis except in medicines containing 5% or less and
in tubes containing 3 grams or less

Amethocaine; for external use in medicines containing 10%
or less and more than 2%

Atropa belladonna; for external use in medicines containing
0.03% of the alkaloids of belladonna; for oral use in
liquid form in medicines containing 0.03% or less and
0.3 milligrams or less per dose and not more than 1.2
milligrams per recommended daily dose of the alkaloids
of belladonna or in solid dose form in medicines
containing 0.3 milligrams or less per dose form and
not more than 1.2 milligrams per recommended daily
dose of the alkaloids of belladonna

Atropine; for oral use in liquid form in medicines containing
0.03% or less and 0.3 milligrams or less per dose and
not more than 1.2 milligrams per recommended daily
dose or in solid dose form in medicines containing
0.3 milligrams or less per dose form and not more than 1.2
milligrams per recommended daily dose; in medicines
containing atropine sulfate for the treatment of
organophosphorous poisoning either in packs of up to
20 tablets containing 0.6 milligrams or less per tablet
or in injections in packs of 5 or less containing 0.6
milligrams per millilitre or less; except when used as an
antidote in a device designed for self-injection; except
when sold by licencees under the Toxic Substances
Regulations

Beclomethasone; in aqueous nasal sprays delivering up
to 50 micrograms per actuation when the maximum
recommended daily dose is not greater than 400
micrograms and the medicine has received the consent
of the Minister or the Director-General to its distribution
as a pharmacy-only medicine

Benzocaine; for external use in medicines containing 10%
or less and more than 2%

Benzydamine; for external use

Bifonazole; for external use except in medicines for tinea
pedis only or in shampoos containing 1% or less

Budesonide; in aqueous nasal sprays delivering up to
50 micrograms per actuation when the maximum
recommended daily dose is not greater than 400
micrograms and the medicine has received the consent
of the Minister or the Director-General to its distribution
as a pharmacy-only medicine

Ciclopirox; for dermal use in medicines containing 2% or
less except in medicines for tinea pedis only

Cinchocaine; for external use in medicines containing 0.5%
or less

Datura spp; for oral use in liquid form in medicines
containing 0.03% or less and 0.3 milligrams or less per
dose and not more than 1.2 milligrams per recommended
daily dose of total solanaceous alkaloids or in solid dose
form in medicines containing 0.3 milligrams or less
per dose form and not more than 1.2 milligrams per
recommended daily dose of total solanaceous alkaloids

12 AUGUST 2004

Dextromethorphan; in liquid form containing more than
0.25% or in solid dose form containing more than 15
milligrams per dose form when in packs containing not
more than 600 milligrams and with a recommended daily
dose of not more than 120 milligrams

Diclofenac; in solid dose form containing 12.5 milligrams or
less per dose form in packs of not more than 20 tablets
or capsules

Duboisia leichhardtii; for oral use in liquid form in
medicines containing 0.03% or less and 0.3 milligrams
or less per dose and not more than 1.2 milligrams per
recommended daily dose of total solanaceous alkaloids
or in solid dose form in medicines containing 0.3
milligrams or less per dose form and not more than
1.2 milligrams per recommended daily dose of total
solanaceous alkaloids

Duboisia myoporides; for oral use in liquid form in
medicines containing 0.03% or less and 0.3 milligrams
or less per dose and not more than 1.2 milligrams per
recommended daily dose of total solanaceous alkaloids
or in solid dose form in medicines containing 0.3
milligrams or less per dose form and not more than
1.2 milligrams per recommended daily dose of total
solanaceous alkaloids

Fluorides; for internal use in medicines containing 2.2
milligrams or less per dose form of sodium fluoride; for
external use in medicines other than pastes, gels or
powders for cleaning the teeth containing 2.5% or less;
except in oral hygiene products other than pastes, gels or
powders for cleaning the teeth containing 0.01% or less

Flurbiprofen; in throat lozenges containing 10 milligrams or
less per lozenge

Fluticasone; in aqueous nasal sprays delivering up to
50 micrograms per actuation when the maximum
recommended daily dose is not greater than 200
micrograms and the medicine has received the consent of
the Minister or the Director-General to its distribution as
a pharmacy-only medicine

Folic acid; for oral use in medicines containing more than
500 micrograms per recommended daily dose

Folinic acid; for oral use in medicines containing more than
500 micrograms per recommended daily dose

Glyceryl trinitrate; for external use; except in medicines
containing 100 micrograms or less per litre or per
kilogram

Hydroquinone; for external use in medicines containing 2%
or less except in hair preparations containing 1% or less

Hyoscine; for transdermal use in medicines containing
2 milligrams or less of total solanaceous alkaloids per
dose unit; for oral use in liquid form in medicines
containing 0.03% and 0.3 milligrams or less per dose
and not more than 1.2 milligrams per recommended
daily dose or in solid dose form in medicines containing
0.3 milligrams or less per dose unit and not more than 1.2
milligrams per recommended daily dose of total
solanaceous alkaloids

Hyoscyamine; for external use in medicines containing
0.03% or less of total solanaceous alkaloids; for oral use
in liquid form in medicines containing 0.03% and
0.3 milligrams or less per dose and not more than 1.2
milligrams per recommended daily dose or in solid dose
form in medicines containing 0.3 milligrams or less
per dose unit and not more than 1.2 milligrams per
recommended daily dose of total solanaceous alkaloids

Hyoscyamus niger; for oral use in liquid form in medicines
containing 0.03% and 0.3 milligrams or less per dose
and not more than 1.2 milligrams per recommended
daily dose of total solanaceous alkaloids or in solid dose
form in medicines containing 0.3 milligrams or less